查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403336

全球毒理学测试市场预测（-2030）：按产品、测试类型、方法、技术、最终用户和地区进行分析

Toxicology Testing Market Forecasts to 2030 - Global Analysis By Product, Test Type, Method, Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

预测期内，全球毒性测试市场规模将以 15.9% 的复合年增长率成长。

毒理学测试涉及评估物质对生物体的影响，以评估对人类健康或环境的潜在危害。确定与化学品、药品、消费品和环境污染物相关的安全性、毒性和风险。其重要性在于透过识别和减轻风险、支持监管合规性以及指南产品开发来保护公众健康。

根据 NCBI 的数据，在发现阶段合成的每 10,000 种化合物中，只有 250 种达到临床前阶段，并且有一种药物最终获得 FDA核准。

增加研发活动

製药、生物技术和化学製造等行业不断寻找新的化合物、配方和产品。毒理学测试在这些领域发挥着至关重要的作用，在这些创新技术引入市场之前对其安全性、有效性和潜在风险进行评估。此外，强大的毒性评估可确保符合监管标准，并有助于减少对人类健康和环境的不利影响。随着消费者需求的变化和技术突破，研发工作不断增加，彻底的毒性测试的需求也在增加，这对于新药、化学品和产品的创造和核准至关重要。这是一个步骤。

资料解释的复杂性

许多实验和最尖端科技产生的复杂多样的资料使得分析具有挑战性，并且难以转化为有用的见解。准确评估这种复杂性需要特定的知识、先进的设备和标准化的框架。解释此类复杂统计资料时的错误和不确定性可能会损害风险评估、监管备案和产品开发中的决策，并可能阻碍市场核准和开发。

对替代测试方法的需求不断增长

试管内测定、类器官、微流体系统和计算模型等先进技术为毒性评估提供了有前途的替代方案，提供更准确、更具成本效益和道德的测试工具。投资研发以检验这些替代品并将其商业化的公司将能够利用这种不断增长的需求。此外，这些替代品的广泛采用将简化测试过程并提供更快的结果，这符合更人性化和可预测的毒性评估的全球趋势。这样，就成为了市场拓展的动力。

监管变化

不断发展和收紧的安全评估法规会影响测试方法、验证要求和产品核可时间表，需要不断调整和遵守。监管标准的突然变化或新指南的引入可能会导致不确定性、成本增加和核准过程的延迟。如果无法快速回应新标准，可能会导致违规处罚、竞争力下降和市场准入减少，从而使毒理学测试市场难以保持效率并应对不断变化的要求，这给企业带来了挑战。

COVID-19 的影响

由于业务关闭和研究影响，COVID-19 爆发最初导致资源重新转向与大流行相关的研究。测试和监管流程继续延迟，导致产品核准延迟。然而，这场危机凸显并提高了毒性测试在疫苗开发和药物安全评估中的重要性。业界以远距工作和虚拟考试作为回应，刺激了创新和数数位化。对安全评估意识的提高导致人们重新重视稳健的调查方法，为疫情后的恢復铺路。

遗传毒性测试部分预计将在预测期内成为最大的部分

遗传毒性测试部分估计占最大份额。遗传毒性测试采用评估物质诱导突变、染色体畸变和 DNA 损伤的能力的分析方法，对于识别潜在的致癌物质和有害化合物至关重要。这些试验包括Ames试验、微核试验、彗星试验等体外及体内方法，综合分析遗传毒性。此外，了解基因毒性有助于确定药物、化学物质、农药和消费品的安全性，并为监管评估做出巨大贡献，以确保人类健康和环境免受有害的基因变化的影响。

体内测试领域预计在预测期内复合年增长率最高。

预计体内测试领域在预测期内将出现良好的成长。体内测试是对整个活体（例如植物或动物）进行的实验类型。它有助于确定毒性水平、不良反应和潜在的健康危害，为监管和安全评估提供关键资料。此外，儘管存在伦理方面的考虑，这些测试对于全面了解物质的生物效应并确保保护人类健康和环境免受潜在有害化合物的侵害至关重要。

比最大的地区

由于工业化程度不断提高、监管指南更加严格以及环境安全意识不断增强，亚太地区在预测期内占据了最大的市场占有率。技术进步、製药和生物技术领域的扩张以及化妆品和食品行业对毒性评估的需求正在推动市场扩张。此外，中国、印度、日本和韩国等国家正在透过扩大经济和扩大研究倡议做出重要贡献。推动该市场成长的是对产品安全评估的重视以及对可靠毒性测试方法的需求。

复合年增长率最高的地区：

由于严格的法律规范、对产品安全的日益关注和技术进步，预计北美在预测期内将实现盈利增长。该地区拥有成熟的製药和生物技术产业，研发活动不断增加，因此市场预计将扩大。此外，对化学品暴露的日益关注以及医疗、化妆品和环境监测等各个领域对有效毒性评估的需求正在推动市场成长。美国和加拿大等主要贡献国家见证了测试方法的不断进步，推动了创新和市场渗透。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球毒理学测试市场：按产品

  • 装置
  • 试剂和套件
  • 其他产品

第六章全球毒理学测试市场：依测试类型

  • 遗传毒性测试
  • 致癌性试验
  • 发育/生殖毒性测试
  • 其他考试类型

第七章全球毒理学测试市场：依方法

  • 生化测试
  • 血液学检查
  • 病理检查

第八章全球毒理学测试市场：依技术分类

  • 体内测试
  • 体外试验

第九章全球毒理学测试市场：依最终用户分类

  • 食品工业
  • 製药和生物技术公司
  • 化妆品及个人护理行业
  • 学术研究所
  • 其他最终用户

第十章全球毒理学测试市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十一章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司简介

  • Abbott Laboratories
  • Eurofins Scientific
  • Laboratory Corporation Of America Holdings
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Agilent Technolgies, Inc.
  • Catalent, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bioivt
  • Gentronix
Product Code: SMRC24561

According to Stratistics MRC, the Global Toxicology Testing Market is growing at a CAGR of 15.9% during the forecast period. Toxicology testing involves evaluating the effects of substances on living organisms to assess potential hazards to human health and the environment. It determines the safety, toxicity, and risks associated with chemicals, pharmaceuticals, consumer products, and environmental pollutants. Its importance lies in safeguarding public health by identifying and mitigating risks, aiding regulatory compliance, and guiding product development.

According to NCBI, for every 10,000 compounds synthesized in the discovery phase, only 250 reach the preclinical phase, ultimately resulting in one approved drug by the FDA.

Market Dynamics:

Driver:

Increasing R&D activities

Industries such as pharmaceuticals, biotechnology, and chemical manufacturing are continually exploring novel compounds, formulations, and products. Toxicology testing plays a pivotal role in these sectors by evaluating the safety, efficacy, and potential risks of these innovations before market introduction. Moreover, robust toxicological assessments ensure compliance with regulatory standards and help mitigate adverse effects on human health and the environment. The need for thorough toxicological testing is growing as R&D efforts to address changing consumer demands and technological breakthroughs rise, making it an essential step in the creation and approval of novel medications, chemicals, and products.

Restraint:

Complexity in data interpretation

The complex and varied data produced by many experiments and cutting-edge technologies presents analytical difficulties that make it difficult to analyze and translate into useful insights. Accurate assessment of this complexity necessitates specific knowledge, advanced instruments, and standardized frameworks. Errors or uncertainty when interpreting these complex statistics can impair decision-making in risk assessments, regulatory filings, and product development, thereby impeding market approvals and developments.

Opportunity:

Growing demand for alternative testing methods

Advanced technologies such as in vitro assays, organoids, microfluidics systems, and computational models offer promising alternatives for toxicology assessments, providing more accurate, cost-effective, and ethical testing avenues. Companies investing in research and development to validate and commercialize these alternative methods stand to capitalize on this growing demand. Moreover, the widespread adoption of these alternatives also streamlines testing processes, fosters quicker results, and aligns with the global trend towards more humane and predictive toxicology evaluations. Thus, there is propelling market expansion.

Threat:

Regulatory changes

Evolving and stringent regulations governing safety assessments necessitate continuous adaptation and compliance, impacting testing methodologies, validation requirements, and timelines for product approvals. Sudden shifts in regulatory standards or the introduction of new guidelines may lead to uncertainties, increased costs, and delays in the approval process. Failure to promptly align with new standards could result in non-compliance penalties, reduced competitiveness, and impediments to market access, posing challenges for companies in maintaining efficiency and meeting evolving requirements within the toxicology testing market.

COVID-19 Impact

The COVID-19 outbreak initially affected operations and research due to lockdowns and redirected resources towards pandemic-related studies. Delays in trials and regulatory processes ensued, slowing down product approvals. However, the crisis highlighted the criticality of toxicology testing in vaccine development and drug safety assessments, elevating its importance. The industry adapted with remote work and virtual trials, fostering innovation and digitalization. Increased awareness of safety evaluations resulted in a renewed emphasis on robust testing methodologies, paving the way for a resilient recovery post-pandemic.

The genetic toxicology testing segment is expected to be the largest during the forecast period

The genetic toxicology testing segment is estimated to hold the largest share. Genetic toxicology testing employs assays to evaluate a substance's ability to induce mutations, chromosomal aberrations, or DNA damage, which is crucial in identifying potential carcinogens or harmful compounds. These tests encompass in vitro and in vivo methods, such as the Ames test, micronucleus assay, and comet assay, to comprehensively analyze genotoxicity. Moreover, understanding genetic toxicity aids in determining the safety of pharmaceuticals, chemicals, pesticides, and consumer products, contributing significantly to regulatory evaluations, and ensuring the protection of human health and the environment from harmful genetic alterations.

The in-vivo testing segment is expected to have the highest CAGR during the forecast period

The in-vivo testing segment is anticipated to have lucrative growth during the forecast period. In vivo tests refer to a type of experiment that is carried out within a whole, living organism, such as a plant or animal. It helps to determine toxicity levels, adverse reactions, and potential health hazards, providing crucial data for regulatory assessments and safety evaluations. Moreover, these tests, despite ethical considerations, remain essential for comprehensively understanding the biological effects of substances and ensuring the protection of human health and the environment from potentially harmful compounds.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing industrialization, stringent regulatory guidelines, and rising awareness regarding environmental safety. Advancements in technology and expanding pharmaceutical and biotechnology sectors, coupled with the demand for toxicological evaluations in the cosmetics and food industries, drive market expansion. Moreover, countries like China, India, Japan, and South Korea are pivotal contributors due to their expanding economies and growing research initiatives. This market's growth is fuelled by the emphasis on product safety assessment and the need for reliable toxicology testing methods.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, due to stringent regulatory frameworks, heightened focus on product safety, and technological advancements. The region's well-established pharmaceutical and biotechnology industries, along with increased R&D activities, propel market expansion. Moreover, rising concerns about chemical exposure, coupled with the need for efficient toxicological evaluations in various sectors, including healthcare, cosmetics, and environmental monitoring, are driving market growth. Key contributors like the United States and Canada witness continual advancements in testing methodologies, fostering innovation and market penetration.

Key players in the market:

Some of the key players in the Toxicology Testing Market include Abbott Laboratories, Eurofins Scientific, Laboratory Corporation Of America Holdings, Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technolgies, Inc., Catalent, Inc., Bio-Rad Laboratories, Inc., Bioivt and Gentronix.

Key Developments:

In November 2023, Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences.

In October 2023, Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Meridian™ EX System- an electron-beam-based failure analysis solution designed to enable precise fault localization on advanced semiconductor logic technologies.

In September 2023, Thermo Fisher Scientific and National Minority Quality Forum Collaborate to support biopharmaceutical and biotech customers in meeting regulatory expectations to enroll and retain patients in clinical trials who more fully reflect real-world populations experiencing the disease or health condition being studied, including U.S. Food and Drug Administration requirements around diversity action plans.

Products Covered:

  • Instruments
  • Reagents and Kits
  • Other Products

Test Types Covered:

  • Genetic Toxicology Testing
  • Carcinogenicity Testing
  • Developmental and Reproductive Toxicology Testing
  • Other Test Types

Methods Covered:

  • Biochemical Testing
  • Hematology Testing
  • Pathology Testing

Technologies Covered:

  • In-vivo Testing
  • In-vitro Testing

End Users Covered:

  • Food and Beverage Industry
  • Pharmaceutical and Biotechnology Companies
  • Cosmetics and Personal Care Industry
  • Academic and Research Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Toxicology Testing Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
  • 5.3 Reagents and Kits
  • 5.4 Other Products

6 Global Toxicology Testing Market, By Test Type

  • 6.1 Introduction
  • 6.2 Genetic Toxicology Testing
  • 6.3 Carcinogenicity Testing
  • 6.4 Developmental and Reproductive Toxicology Testing
  • 6.5 Other Test Types

7 Global Toxicology Testing Market, By Method

  • 7.1 Introduction
  • 7.2 Biochemical Testing
  • 7.3 Hematology Testing
  • 7.4 Pathology Testing

8 Global Toxicology Testing Market, By Technology

  • 8.1 Introduction
  • 8.2 In-vivo Testing
  • 8.3 In-vitro Testing

9 Global Toxicology Testing Market, By End User

  • 9.1 Introduction
  • 9.2 Food and Beverage Industry
  • 9.3 Pharmaceutical and Biotechnology Companies
  • 9.4 Cosmetics and Personal Care Industry
  • 9.5 Academic and Research Institutions
  • 9.6 Other End Users

10 Global Toxicology Testing Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Laboratories
  • 12.2 Eurofins Scientific
  • 12.3 Laboratory Corporation Of America Holdings
  • 12.4 Thermo Fisher Scientific, Inc.
  • 12.5 Danaher Corporation
  • 12.6 Agilent Technolgies, Inc.
  • 12.7 Catalent, Inc.
  • 12.8 Bio-Rad Laboratories, Inc.
  • 12.9 Bioivt
  • 12.10 Gentronix

List of Tables

  • Table 1 Global Toxicology Testing Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 4 Global Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
  • Table 5 Global Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 6 Global Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 7 Global Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
  • Table 8 Global Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
  • Table 9 Global Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
  • Table 10 Global Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 11 Global Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 12 Global Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
  • Table 13 Global Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
  • Table 14 Global Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
  • Table 15 Global Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 16 Global Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
  • Table 17 Global Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 18 Global Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 19 Global Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
  • Table 20 Global Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 21 Global Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
  • Table 22 Global Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
  • Table 23 Global Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 24 North America Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 25 North America Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 26 North America Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 27 North America Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
  • Table 28 North America Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 29 North America Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 30 North America Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
  • Table 31 North America Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
  • Table 32 North America Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
  • Table 33 North America Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 34 North America Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 35 North America Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
  • Table 36 North America Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
  • Table 37 North America Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
  • Table 38 North America Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 39 North America Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
  • Table 40 North America Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 41 North America Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
  • Table 43 North America Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 44 North America Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
  • Table 45 North America Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
  • Table 46 North America Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 47 Europe Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 48 Europe Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 49 Europe Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 50 Europe Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
  • Table 51 Europe Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 52 Europe Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 53 Europe Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
  • Table 54 Europe Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
  • Table 55 Europe Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
  • Table 56 Europe Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 57 Europe Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 58 Europe Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
  • Table 59 Europe Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
  • Table 60 Europe Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
  • Table 61 Europe Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 62 Europe Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
  • Table 63 Europe Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 64 Europe Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 65 Europe Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
  • Table 66 Europe Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 67 Europe Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
  • Table 68 Europe Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
  • Table 69 Europe Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 70 Asia Pacific Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 71 Asia Pacific Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 72 Asia Pacific Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 73 Asia Pacific Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
  • Table 74 Asia Pacific Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 75 Asia Pacific Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 76 Asia Pacific Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
  • Table 77 Asia Pacific Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
  • Table 78 Asia Pacific Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
  • Table 79 Asia Pacific Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 80 Asia Pacific Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 81 Asia Pacific Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
  • Table 82 Asia Pacific Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
  • Table 83 Asia Pacific Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
  • Table 84 Asia Pacific Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 85 Asia Pacific Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
  • Table 86 Asia Pacific Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 87 Asia Pacific Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 88 Asia Pacific Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
  • Table 89 Asia Pacific Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 90 Asia Pacific Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
  • Table 91 Asia Pacific Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
  • Table 92 Asia Pacific Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 93 South America Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 94 South America Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 95 South America Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 96 South America Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
  • Table 97 South America Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 98 South America Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 99 South America Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
  • Table 100 South America Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
  • Table 101 South America Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
  • Table 102 South America Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 103 South America Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 104 South America Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
  • Table 105 South America Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
  • Table 106 South America Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
  • Table 107 South America Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 108 South America Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
  • Table 109 South America Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 110 South America Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 111 South America Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
  • Table 112 South America Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 113 South America Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
  • Table 114 South America Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
  • Table 115 South America Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 116 Middle East & Africa Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 117 Middle East & Africa Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 118 Middle East & Africa Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 119 Middle East & Africa Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
  • Table 120 Middle East & Africa Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 121 Middle East & Africa Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 122 Middle East & Africa Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
  • Table 123 Middle East & Africa Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
  • Table 124 Middle East & Africa Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
  • Table 125 Middle East & Africa Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 126 Middle East & Africa Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 127 Middle East & Africa Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
  • Table 128 Middle East & Africa Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
  • Table 129 Middle East & Africa Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
  • Table 130 Middle East & Africa Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 131 Middle East & Africa Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
  • Table 132 Middle East & Africa Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 133 Middle East & Africa Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 134 Middle East & Africa Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
  • Table 135 Middle East & Africa Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 136 Middle East & Africa Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
  • Table 137 Middle East & Africa Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
  • Table 138 Middle East & Africa Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)